Moderna Shares Skyrocket 85% Toward Best Day Ever—On Success Of Cancer Drug Trial

Moderna Shares Skyrocket 85% Toward Best Day Ever—On Success Of Cancer Drug Trial
The trial marked the first successful final-stage study for any mRNA-based cancer therapy.